Medicofarma Biotech SA (WSE:MDB)
0.4500
0.00 (0.00%)
At close: Jun 5, 2026
Nations Trust Bank Revenue
Medicofarma Biotech had revenue of 36.00K PLN in the quarter ending March 31, 2026, a decrease of -67.86%. This brings the company's revenue in the last twelve months to 43.90K, down -90.55% year-over-year. In the year 2025, Medicofarma Biotech had annual revenue of 119.90K, down -90.21%.
Revenue (ttm)
43.90K
Revenue Growth
-90.55%
P/S Ratio
696.82
Revenue / Employee
3.14K
Employees
14
Market Cap
30.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 119.90K | -1.10M | -90.21% |
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 706.45M |
| Voxel | 583.79M |
| BioMaxima | 60.90M |
| Sygnis | 13.02M |
| Pharmena | 1.61M |
| Nestmedic | 1.02M |